Brief: Diamyd Medical Fully Subscribes To Its Pro Rata Share In NextCell Pharma's Rights Issue

NextCell Pharma AB

10/06/2019 10:19

June 10 (Reuters) - Diamyd Medical AB  DMYDb.ST :
    * DIAMYD MEDICAL FULLY SUBSCRIBES TO ITS PRO RATA SHARE IN
NEXTCELL PHARMA'S RIGHTS ISSUE
    * DIAMYD MEDICAL INVESTS ITS PRO RATA SHARE CORRESPONDING TO
APPROXIMATELY SEK 3.2 MILLION IN ASSOCIATED COMPANY NEXTCELL
PHARMA'S ONGOING RIGHTS ISSUE
    * CO'S BOOK VALUE OF HOLDING IN NEXTCELL PHARMA AFTER
INVESTMENT
INCREASES FROM APPROXIMATELY SEK 5.3 MILLION TO APPROXIMATELY
SEK 8.5 MILLION

Source text for Eikon:  ID:nWkrbbhRWy 
Further company coverage:  DMYDb.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))